Contemporary therapies for chronic heart failure with reduced ejection fraction
Heart failure with reduced ejection fraction (HFrEF) is common, and without optimal guideline-mandated medical therapy, is disabling and fatal. As trials discover effective additional HFrEF therapies, it is essential that all healthcare practitioners develop competence in treating these patients optimally. This narrative review discusses the approach to the contemporary medical management of HFrEF.
The full article is available at https://doi.org/10.36303/SAGP.2020.1.4.0026